7 Opioid peptides and depression: the neuroendocrine approach

Bailliere's Clinical Endocrinology and Metabolism

Volumn 5, Issue 1, 1991, Pages 97-117

  Zis, Athanasios P ^a   Garland, Jane E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; FENTANYL; HYDROCORTISONE; METHADONE; MORPHINE; NALOXONE; PROLACTIN;

DEPRESSION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; REVIEW;

ADRENAL GLANDS; DEPRESSION; ENDOCRINE GLANDS; ENDORPHINS; HUMAN; HYPOTHALAMUS; NERVOUS SYSTEM; PITUITARY GLAND; PROLACTIN; SUPPORT, NON-U.S. GOV'T;

EID: 0026071205     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(05)80099-0     Document Type: Article

References (111)

1. Effects of met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion
2. 1–24) stimulation test in depressed patients and healthy subjects
3. Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers
4. Multiple hormonal responses to morphine: relationship to diagnosis and dexamethasone suppression
5. The effect of naloxone on ACTH and endorphin in patients with Cushing's disease
6. Estrogen-dependent plasma prolactin response to gonadotropin-releasing hormone in intact and castrated men
7. Prolactin in patients with major depressive disorder and in healthy subjects: I. Cross-sectional study of basal and post-TRH and postdexamethasone prolactin levels
8. Opioid peptides in affective disorders
9. Investigating opioid peptides in schizophrenia and depression
10. Beta-endorphin attenuates the serum cortisol response to exogenous adrenocorticotropin
11. Endorphins are located in the intermediate and anterior lobes of the pituitary gland, not in the neurohypophysis
12. Effects of adrenergic antagonism on the growth hormone, prolactin and cortisol response to a synthetic opioid agonist in man
13. Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide
14. Opioids and hypothalamic—pituitary adrenocorticotrophic activity in the rat
15. Cushing's disease. A review
16. Growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone following diethylstilbestrol pretreatment
17. Limbic system-adrenal cortex regulation in depression and schizophrenia
18. Neurotransmitter studies of neuroendocrine pathology in depression
19. A specific laboratory test for the diagnosis of melancholia. Standardization, validation and clinical utility
20. Intravenous infusion of beta-endorphin increases serum prolactin, but not growth hormone or cortisol, in depressed subjects and withdrawing methadone addicts
21. High-dose naloxone infusions in normals
22. Plasma prolactin concentrations following epileptic and pseudo-seizures
23. Effect of naloxone on the hormone response to CRF in normal man
24. Methadone induced hypoadrenalism
25. Prolactin-releasing activity of dermorphin, a new synthetic potent opiate-like peptide, in normal human subjects
26. Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion
27. Relation of opiates to hormonal secretion in man
28. Inhibitory action of a met-enkephalin on ACTH release in man
29. Effects of high-dose and low-dose naloxone on plasma ACTH in patients with ACTH hypersecretion
30. Increased adrenal weight in victims of violent suicide
31. Potentiation of hCRF-induced release of ACTH in man by an opioid antagonist
32. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and Cushing's disease
33. Possible role of opioids in mental disorders. Present state of knowledge
34. Identification of proopiomelanocortin derived peptides in human adrenal medulla
35. Deficient prolactin response to morphine in depressed patients
36. A possible receptor of dysfunction in some depressive disorders
37. Prolactin response to Fentanyl in depression
38. The effects of a met-enkephalin analogue on ACTH, beta-endorphin and met-enkephalin in patients with adrenocortical disease
39. Effect of codeine and oxazepam on afternoon cortisol secretion in men
40. Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency
41. Suppression of plasma cortisol in depressed patients by acute intravenous methadone infusion
42. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnosis implications
43. Opiates control ACTH through a noradrenergic mechanism
44. Opiate receptors: enkephalins and endorphins
45. An analogue of met-enkephalin attenuates the pituitary—adrenal response to ovine corticotropin releasing factor
46. Different opioid mechanisms are involved in the modulation of gonadotrophin and ACTH release in man
47. Beta-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland
48. Hormone response to repeated electroconvulsive therapy: Effects of naloxone
49. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects
50. Prolactin response to thyrotropin-releasing hormone in normal subjects
51. Enhanced adrenal sensitivity to exogenous cosyntropin (ACTH 1–24) stimulation in major depression
52. Prolactin secretion during sleep: a comparison between depressed patients and healthy control subjects
53. Effects of naloxone-hydrochloric on cortisol levels in patients with affective disorder and normal controls
54. Blunted prolactin response. A neuroendocrine abnormality manifested by depressed patients
55. The effect of a methadone challenge on the prolactin and growth hormone responses of psychiatric patients and normal controls
56. Effect of naloxone on plasma adrenocorticotropin levels and β-endorphin-like immunoreactivity in bilaterally adrenalectomized patients with Cushing's disease and in Addison's disease
57. Probable precursors of [leu]enkephalin and [met]enkephalin in adrenal medulla: peptides of 3–5 kilodaltons
58. A met-enkephalin analog inhibits adrenocorticotropin secretion by cultured pituitary cells from a patient with Nelson's syndrome
59. The 24 hour profile of plasma prolactin in men with major endogenous depressive illness
60. Effect of morphine and nalorphine on plasma hydrocortisone levels in man.
61. Nocturnal secretion in depression
62. Common precursor to corticotropins and endorphins
63. Failure of naloxone to alter exercise-induced growth hormone and prolactin release in normal men
64. Naloxone but not CCK-8 may attenuate binge-eating in patients with the bulimia syndrome
65. The effect of low-dose naloxone infusion on plasma ACTH and LH in patients with Cushing's and Addison's diseases
66. Naloxone inhibits exercise-induced release of PRL and GH in athletes
67. The endocrinology of the opiates and opioid peptides
68. Endocrine effects of naloxone-induced opiate receptor blockade
69. Opioid modulation of appetite
70. Endocrine Actions of Opioids
71. Prolactin response to electroconvulsive therapy
72. Naloxone fails to block ECT-induced prolactin increase
73. Opioid receptors
74. Hypothalamic—pituitary—adrenal abnormalities in depression: their possible relation to central mechanisms regulating ACTH release
75. Endocrine actions of opioids
76. Pituitary—adrenal axis rhythm disturbances in psychiatric depression
77. Effects of naloxone on prolactin, luteinizing hormone, and cortisol responses to surgical stress in humans
78. Adrenal cortex—a newly recognized peripheral site of action of enkephalins
79. Morphine inhibits the pituitary—adrenal response to ovine corticotropin-releasing hormone in normal subjects
80. Prolactin response to morphine in depression
81. Endocrine abnormalities in depression
82. Disrupted 24-hour patterns of cortisol secretion in psychotic depression
83. A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease
84. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsitivity in depression
85. Prolactin in partial epilepsy: an indicator of limbic seizures
86. Lack of effect of naloxone on prolactin and seizures in electroconvulsive therapy
87. Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors
88. Pretreatment DST and hypothalamic—pituitary—adrenocortical function in depressed patients and comparison groups
89. Hormonal and metabolic responses to an enkephalin analogue in normal man
90. Beta-endorphin suppresses adrenocorticotropin and cortisol-levels in normal human subjects
91. Effect of naloxone on pituitary hypersecretory syndromes
92. Modulation of endogenous opioid systems by electroconvulsive shock
93. Serum prolactin in epilepsy and hysteria
94. Neurotransmitter regulation of anterior pituitary hormones
95. Naloxone has no effect on hormonal responses to ECT in man
96. Characterization of a 41 residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
97. Naloxone increases ACTH and cortisol levels in man
98. Evidence for two separate opiate peptide neuronal systems
99. Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy
100. Synthesis of enkephalins by adrenal medullary chromaffin cells: reserpine increases incorporation of radiolabeled amino acids
101. Single-dose naloxone acutely reduces eating in obese humans: behavioural and biochemical effects
102. Effect of the plasma estrone/17 beta-estradiol ratio on the prolactin and TSH responses to TRH
103. Neuroendocrinology of opioid peptides and their role in the gonadotropin and prolactin secretion
104. Escape from dexamethasone suppression: possible role of an impaired inhibitory opioid mechanism
105. Morphine inhibits cortisol and stimulates prolactin secretion in man
106. Opioid regulation of hypothalamic—pituitary—adrenal function in depression
107. Cortisol escape from morphine suppression
108. Prolactin response to morphine in depression
109. Prolactin response to TRH in depression
110. Cortisol response to naloxone in depression
111. Effect of morphine on cortisol and prolactin secretion in anorexia nervosa and depression